hotspot -WSS

hotspot

author：entertainment 2025-09-30 23:05:54 - browse：8715

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Supreme Court strikes down use of affirmative action
Next article： Diversifying clinical trials isn't enough to close racial gaps: study

leisure time

WSS

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Merck drug for rare lung condition set for approval in U.S.

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: What happened with Sarepta's Duchenne data

Traditional Chinese medicine benefits explored in new JAMA study

Medtronic CEO on promising devices for diabetes, hypertension

leisure time

hotspot

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

CDC recommends rationing of RSV shot due to shortages

Duchenne breakthrough therapy leaves behind pioneering families

Biden's order seeks to regulate AI risk without stifling innovation

Wildfire smoke exposes gaps in outdoor worker protections

FDA has safety concerns on CRISPR

Medical records are filled with copy

CDC recommends rationing of RSV shot due to shortages

Apple is now the first public company to be valued at $3 trillion

Diversifying clinical trials isn't enough to close racial gaps: study

hotspot

Traditional Chinese medicine benefits explored in new JAMA study

Diversifying clinical trials isn't enough to close racial gaps: study

Why the world’s most expensive drug might be worth the price

States should stop sabotaging methadone treatment reform

FDA has safety concerns on CRISPR

Vertex Pharmaceuticals may move headquarters in Boston

Wikipedia

leisure time

hotspot

knowledge